NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Metrics
Affected Vendors & Products
References
History
Thu, 04 Dec 2025 16:45:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| First Time appeared |
Microsoft
Microsoft windows Mirion Medical Mirion Medical nmis Biodose |
|
| Vendors & Products |
Microsoft
Microsoft windows Mirion Medical Mirion Medical nmis Biodose |
Tue, 02 Dec 2025 22:15:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Metrics |
ssvc
|
Tue, 02 Dec 2025 21:15:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Description | NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection. | |
| Title | Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication | |
| Weaknesses | CWE-603 | |
| References |
| |
| Metrics |
cvssV3_1
|
Status: PUBLISHED
Assigner: icscert
Published: 2025-12-02T21:07:47.995Z
Updated: 2025-12-02T21:39:30.055Z
Reserved: 2025-11-11T20:56:52.843Z
Link: CVE-2025-61940
Updated: 2025-12-02T21:39:24.460Z
Status : Awaiting Analysis
Published: 2025-12-02T21:15:51.930
Modified: 2025-12-04T17:15:08.283
Link: CVE-2025-61940
No data.